Technivie (ombitasvir/paritaprevir/ritonavir) / AbbVie  >>  Phase 4
Welcome,         Profile    Billing    Logout  

6 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Technivie (ombitasvir/paritaprevir/ritonavir) / AbbVie
2016-003607-59: An Open-Label Study to Evaluate Long-Term Results With Ombitasvir-Paritaprevir-Ritonavir and Dasabuvir With or Without Ribavirin (RBV) on ovarian function in fertile women With Genotype 1 and 4 Chronic Hepatitis C Virus (HCV) Infection. Studio in aperto per valutare i risultati a lungo termine con Ombitasvir-paritaprevir-Ritonavir e Dasabuvir, con o senza ribavirina (RBV) sulla funzione ovarica delle donne in et¿ fertile con epatite cronica HCV-positiva, genotipo 1 e 4 .

Terminated
4
50
Europe
VIEKIRAX, EXVIERA, 043841, Film-coated tablet, VIEKIRAX - 12,5MG/75MG/50MG COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PVC/PE/PCTFE/ALU) - 56 COMPRESSE (CONFEZIONE MULTIPLA), EXVIERA - 250 MG COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PVC/PE/PCTFE/ALU) - 56 COMPRESSE (CONFEZIONE MULTIPLA)
DIPARTIMENTO AD ATTIVITà INTEGRATA CHIRURGICO, MEDICO, ODONTOIATRICO E DI SCIENZE MORFOLOGICHE, ABBVIE SRL
Genotype 1 and 4 Chronic Hepatitis C Virus (HCV) Infection Epatite cronica HCV-positiva, genotipo 1 e 4, Hepatitis C EPATITE C, Diseases [C] - Virus Diseases [C02]
 
 
NCT02950870: Efficacy Study to Evaluate the Effect of New Antiviral Drugs on HCV Infection.

Unknown status
4
75
Europe
Ombitasvir-Paritaprevir-Ritonavir, Viekirax, Dasabuvir, Exvieria, Ribavirin, RBV
University of Modena and Reggio Emilia
Chronic Hepatitis, C Virus
12/17
12/19
2016-005081-60: NFLUENCE OF TREATMENT WITH DIRECT ANTIVIRAL AGENTS IN THE GLOMERULAR AND TUBULAR FUNCTION OF PATIENTS WITH CHRONIC HCV HEPATITIS NFLUENCIA DEL TRATAMIENTO CON AGENTES ANTIVIRALES DIRECTOS EN LA FUNCIÓN GLOMERULAR Y TUBULAR DE PACIENTES CON HEPATITIS CRÓNICA POR VHC

Terminated
4
200
Europe
SOFOSBUVIR, elbasvir y grazoprevir, ombitasvir,paritaprevir, ritonavir, SIMEPREVIR, Daclastavir, ledipasvir y sofosbuvir, Tablet, Capsule, SOVALDI, ZEPATIER, Viekirax, OLSYO, Daklinza, HARVONI
Jose Luis Calleja Panero, Hospital Universiatrio Puerta de Hierro Majadahonda
Hepatitis C Hepatitis C, Hepatitis C Hepatitis C, Diseases [C] - Virus Diseases [C02]
 
 
2015-001956-31: Direct acting antiviral therapy of hepatitis C in Denmark: treatment response, adverse events and resistance associated variants Behandling af hepatitis C med direkte virkende antivirale præparater i Danmark: behandlingsrespons, bivirkninger, og udvikling af viral resistens

Completed
4
111
Europe
Epclusa, , Tablet, Harvoni, Sovaldi, Viekirax PAK, Daklinza, Rebetol, Epclusa
Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre., The danish database for hepatitis B and C
Patients with chronic hepatitis C Patienter med kronisk hepatitis C, Patients with a chronic liver diasease caused by a virus called hepatitis C virus. Patienter med kronisk leverbetændelse type C., Diseases [C] - Virus Diseases [C02]
 
 
NCT03003338: MHH-HCV-NPM-Neuropsychiatric Manifestations of HCV-infection During and After Treatment With OBV/PTV/r and DSV

Terminated
4
5
Europe
OBV/PTV/r and DSV, Viekirax and Exviera, Placebo to match OBV/PTV/r and DSV
Hannover Medical School, AbbVie
Hepatitis C, Chronic
10/18
10/18
PIVOTAL, NCT02874066: PrOD for Non-Cirrhotic Patients With HCV-1b Receiving Hemodialysis

Completed
4
46
RoW
PTV/r/OBV/DSV, Viekirax/Exviera
National Taiwan University Hospital, AbbVie
Hepatitis Viruses
10/18
12/18

Download Options